Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Neoplastic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04121039
What this trial is testing

Study of the Apatinib Combine With POF Versus POF in Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaAdvanced Cancer
Fujian Cancer Hospital 116
Early research (Phase 1)Study completedNCT00008177
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+14 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00255801
What this trial is testing

Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 37
Early research (Phase 1)Ended earlyNCT00127101
What this trial is testing

An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)

Who this might be right for
Lymphoma
Merck Sharp & Dohme LLC 23
Large-scale testing (Phase 3)Active Not RecruitingNCT05945901
What this trial is testing

A Phase II/III Study of HR070803 in Combination With Oxaliplatin, 5-fluorouracil, Calcium Folinate and Bevacizumab Versus FOLFOX in Combination With Bevacizumab for First-line Treatment of Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jiangsu HengRui Medicine Co., Ltd. 669
Early research (Phase 1)Ended earlyNCT03429101
What this trial is testing

Poziotinib in Combination With T-DM1 in HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Spectrum Pharmaceuticals, Inc 6
Testing effectiveness (Phase 2)Study completedNCT00508001
What this trial is testing

Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)

Who this might be right for
Carcinoma, Hepatocellular
Genzyme, a Sanofi Company 67
Testing effectiveness (Phase 2)Ended earlyNCT05581719
What this trial is testing

A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy

Who this might be right for
Solid TumorPeritoneal MetastasesPeritoneal Cancer
Enlivex Therapeutics RDO Ltd. 14
Not applicableStudy completedNCT00878267
What this trial is testing

Patient-Reported Outcomes (PRO)-Based Palliative and Hospice Care Practice: A Qualitative Study

Who this might be right for
Advanced Cancer
M.D. Anderson Cancer Center 9
Early research (Phase 1)Study completedNCT01395667
What this trial is testing

Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy in Combination With Bevacizumab-FOLFOX

Who this might be right for
Rectal Cancer
National Taiwan University Hospital 15
Testing effectiveness (Phase 2)Ended earlyNCT02100007
What this trial is testing

ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors

Who this might be right for
Solid Tumors
MEI Pharma, Inc. 46
Early research (Phase 1)Study completedNCT04970992
What this trial is testing

A Pharmacokinetic and Pharmacodynamic Study of DZ-002 in Patients With Advanced Solid Malignancies or Lymphoma

Who this might be right for
Solid TumorLymphoma
Da Zen Theranostics Inc 14
Early research (Phase 1)UnknownNCT04032392
What this trial is testing

Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells

Who this might be right for
Hepatocellular Carcinoma
Beijing 302 Hospital 20
Post-approval studies (Phase 4)Study completedNCT01914692
What this trial is testing

Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection

Who this might be right for
Gastric Cancer After D2 Lymph Node Dissection
First Affiliated Hospital, Sun Yat-Sen University 2
Testing effectiveness (Phase 2)Study completedNCT00002656
What this trial is testing

Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Barbara Ann Karmanos Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT01093222
What this trial is testing

Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma

Who this might be right for
Extrahepatic Bile Duct AdenocarcinomaGallbladder AdenocarcinomaGallbladder Adenocarcinoma With Squamous Metaplasia+6 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT01253837
What this trial is testing

L19TNFα in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsColorectal Cancer
Philogen S.p.A. 34
Not applicableLooking for participantsNCT06234137
What this trial is testing

A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrotinib in the Treatment of Local-advanced HER2-positive Breast Cancer

Who this might be right for
Breast Neoplasm Female
Wang Ouchen 154
Testing effectiveness (Phase 2)Study completedNCT04224272
What this trial is testing

Phase 2a Study of ZW25 in Combination With Palbociclib Plus Fulvestrant

Who this might be right for
HER2+/HR+ Breast Cancer
Jazz Pharmaceuticals 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07581795
What this trial is testing

Study of Paclitaxel Polymeric Micelles Combined With HP and Adebelimab Versus Taxane Combined With HP as First-Line Treatment for Advanced HER2-Positive Breast Cancer

Who this might be right for
Advanced HER2-positive Breast Cancer
Fudan University 140
Next Page
79